Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Device, Marks Major Advance for Women’s Health

Butterfly Network Secures First FDA Clearance for Blind Sweep Ultrasound AI Device, Marks Major Advance for Women's Health

BURLINGTON, Mass. & New York–( BUSINESS WIRE )–Butterfly Network, Inc. (“Butterfly,” “The Company”) (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced that it has received approval from the US Food and Drug Administration (FDA) for its fully automated Gestational Age (GA) handheld solution. It marks an … Read more

Pinnacle Medicines, a pioneer in oral peptide therapeutics, announced an additional $89 million in Series B funding to advance its pipeline into clinical trials.

Pinnacle Medicines, a pioneer in oral peptide therapeutics, announced an additional $89 million in Series B funding to advance its pipeline into clinical trials.

The financing was co-led by LAV and Foresite Capital with participation from existing investors including Quan Capital, Hankang Capital, RA Capital Management, Logos Capital and OrbiMed. The company has raised $134 million to date after incubation by OrbiMed and other healthcare specialist investors. Achievements will support the advancement of the oral peptide pipeline through clinical … Read more